BioMark Diagnostics Inc.
BUX
Kedudukan dalam Saham
#26716
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Harga Saham
$0.33433516
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$35.60M
Perubahan (1 hari)
-3.08%
Perubahan (1 tahun)
36.77%
Negara
CA
Perdagangan BioMark Diagnostics Inc. (BUX)
Kategori
Healthcare
Sejarah harga saham bagi BioMark Diagnostics Inc. (BUX)
Harga penutupan tertinggi: $0.38 pada 2026-10-01
Harga penutupan terendah: $0.35 pada 2015-03-01
Harga penutupan terendah: $0.35 pada 2015-03-01
Sejarah harga saham BioMark Diagnostics Inc. dari 2015 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | 6.73% |
| 2025 | 136.71% |
| 2024 | -19.87% |
| 2023 | 29.58% |
| 2022 | -34.72% |
| 2021 | 122.09% |
| 2020 | -51.07% |
| 2019 | 376.19% |
| 2018 | -44.93% |
| 2017 | -9.77% |
| 2016 | -22.98% |
| 2015 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $694.53 | 24.47% |
US
|
|
| $234.00 | 5.99% |
US
|
|
| $416.01 | 122.61% |
US
|
|
| $22.06 | 54.01% |
CN
|
|
| $177.93 | 22.13% |
US
|
